ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
Vir Biotechnology
The Program Manager will provide senior-level leadership for development program teams, overseeing the Hepatitis Delta Phase III and NDA/BLA-enabling activities. Partnering closely with the Program Executive, the role drives cross‑functional matrix teams, manages integrated timelines, risk, and strategic planning, and ensures execution through the drug development lifecycle.
Headquarters
San Francisco, California, United States
Company Size
501-1000 employees
Founded
2016
Vir Biotechnology is a clinical-stage immunology company that leverages the immune system to address critical unmet medical needs in infectious diseases and oncology. Its pipeline is built on two core technology platforms: a next-generation antibody and T-cell engager platform focused on infectious diseases, and the PRO-XTEN® protease-releasable masking technology applied to oncology and infectious disease. With foundational programs including chronic hepatitis delta, COVID-19, and Ebola, Vir works to engineer antibody-based medicines and deliver potentially transformative treatments to patients worldwide.
Vir BiotechnologyAstellas and Vir Biotechnology Announce Global Strategic Collaboration to Advance PSMA-targeting PRO-XTEN® Dual-masked T-Cell Engager VIR-5500 for the Treatment of Prostate Cancer
3 weeks ago
MarketBeatVir Biotechnology, Inc. (NASDAQ:VIR) Receives Consensus Rating of "Moderate Buy" from Analysts
4 days ago
Yahoo FinanceVir Biotechnology Astellas Deal Puts VIR-5500 And Valuation In Focus
2 weeks ago
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Vir Biotechnology.
160% above the average for this role
Genetic Engineering and Biotechnology NewsAstellas, Vir Biotechnology Launch Up-to-$1.7B Prostate Cancer Collaboration
3 weeks ago
Associate Director, Program Management – Orexin Development Programs
Centessa Pharmaceuticals
Senior Director, Program & Portfolio Management
Vera Therapeutics, Inc.
CMC Program Lead
Telix Pharmaceuticals
USMA TA Program Manager, Senior Manager - Neuroscience
Novartis
CMC Program Lead
Telix Pharmaceuticals
Program Manager
Neurocrine Biosciences
